TILMIUS Trademark

Trademark Overview


On Monday, March 2, 2020, a trademark application was filed for TILMIUS with the United States Patent and Trademark Office. The USPTO has given the TILMIUS trademark a serial number of 88816766. The federal status of this trademark filing is REGISTERED as of Tuesday, May 24, 2022. This trademark is owned by Fresenius Kabi Deutschland GmbH. The TILMIUS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use for the treatment of neurological diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, oncological diseases and disorders and viral infections, excluding pharmaceutical preparations for the treatment of osteoporosis and the prevention of fractures resulting from osteoporosis; pharmaceutical preparations for the treatment of CAR T-cell induced cytokine release syndrome, excluding pharmaceutical preparations for the treatment of osteoporosis and the prevention of fractures resulting from osteoporosis
tilmius

General Information


Serial Number88816766
Word MarkTILMIUS
Filing DateMonday, March 2, 2020
Status700 - REGISTERED
Status DateTuesday, May 24, 2022
Registration Number6727065
Registration DateTuesday, May 24, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 7, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations for human use for the treatment of neurological diseases and disorders, immunological diseases and disorders, inflammatory diseases and disorders, oncological diseases and disorders and viral infections, excluding pharmaceutical preparations for the treatment of osteoporosis and the prevention of fractures resulting from osteoporosis; pharmaceutical preparations for the treatment of CAR T-cell induced cytokine release syndrome, excluding pharmaceutical preparations for the treatment of osteoporosis and the prevention of fractures resulting from osteoporosis

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, March 7, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameFresenius Kabi Deutschland GmbH
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressBad Homburg 61352
DE

Party NameFresenius Kabi Deutschland GmbH
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBad Homburg 61352
DE

Party NameFresenius Kabi Deutschland GmbH
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBad Homburg 61352
DE

Trademark Events


Event DateEvent Description
Tuesday, May 24, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 24, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, April 12, 2022TTAB RELEASE CASE TO TRADEMARKS
Tuesday, April 12, 2022OPPOSITION TERMINATED NO. 999999
Tuesday, April 12, 2022OPPOSITION DISMISSED NO. 999999
Tuesday, October 27, 2020OPPOSITION INSTITUTED NO. 999999
Thursday, July 9, 2020EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, July 7, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 7, 2020PUBLISHED FOR OPPOSITION
Wednesday, June 17, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 29, 2020ELECTRONIC RECORD REVIEW COMPLETE
Friday, May 29, 2020ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Thursday, May 21, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 21, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 21, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 19, 2020TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, April 20, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, April 20, 2020LETTER OF SUSPENSION E-MAILED
Monday, April 20, 2020SUSPENSION LETTER WRITTEN
Saturday, April 18, 2020ASSIGNED TO EXAMINER
Saturday, March 7, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, March 5, 2020NEW APPLICATION ENTERED IN TRAM